When the needs
are real, impact on
change is greater!

A Performance and Quality Improvement Intervention Integrating Molecular Testing to Support Personalized Cancer Care in Lung and Thyroid Cancers

Molecular testing has been underutilized in the diagnosis and treatment of cancer patients, despite its potential to significantly impact clinical decision-making and resulting health outcomes.

This project aimed to evaluate the process and impact of a performance/quality improvement (PI/QI) intervention to optimize the integration of molecular testing for patients with non-small cell lung cancer (NSCLC) or thyroid cancer (TC).

 The PI/QI intervention enabled health care teams at both sites to achieve targeted changes in molecular testing, despite a busy clinical environment. These findings can serve other cancer centers aiming to increase molecular testing integration within their teams and institution.

Read the full article: https://doi.org/10.52519/ACEQI.26.2.1.a2

• Quality Improvement
• ONCO
• 2026

Knowledge, skills and attitudinal gaps in diagnosis and management of Fibrodysplasia Ossificans Progressiva in the United States

This study assesses healthcare provider knowledge, confidence, and management practices related to fibrodysplasia ossificans progressiva (FOP). Findings highlight gaps in recognition of key clinical indications, as well as challenges in patient management, referral pathways and access to specialized care.

The results underscore the need for improved rare disease recognition, multidisciplinary collaboration, and system-level approaches to support timely diagnosis and optimal patient management.

This study was made possible with the support of IPSEN Biopharmaceuticals Inc.

Read the full article: https://doi.org/10.1093/jbmrpl/ziag076

• Environmental Scan
• Rare Diseases
• 2026

From Lab to Bedside Testing: Uncovering Gateways and Roadblocks to Syndromic Multiplex Point-of-Care Testing for Infectious Diseases in Canadian Hospitals

Hospital leaders are under growing pressure to improve efficiency of healthcare—especially during times of high demand (e.g., infectious disease outbreaks). Could faster diagnostic through multiplex point-of-care tests (POCTs) for infectious diseases in the inpatient hospital setting help?

AXDEV conducted an environmental scan with 24 health leaders interviewed across Quebec, Ontario, and British Columbia to explore the facilitators and barriers to implementing multiplex point-of-care tests (POCTs) for infectious diseases in the inpatient hospital setting. The findings highlight how current diagnostic practices, local disease burden and health system integration, hospital management capacity, and anticipated operational impact would shape adoption decisions for this technology.

Link: https://doi.org/10.1177/08404704261422741

The study offers a framework to help health leaders plan the organizational changes required for sustainable implementation.

Funded by bioMérieux Canada.

• Environmental Scan
• Infectious Diseases
• 2026